SavedAdd your journal

Journals / The Turkish Journal of Ear Nose and Throat / 2020 / Cilt: 30 - Sayı: 1

Hyperbaric oxygen therapy: The last remedy for sudden sensorineural hearing loss?

Yüksel OLLGUN
Fatih Yunus EMRE
ASLI ÇAKIR
Günay KIRKIM
Hülya ELLİDOKUZ
Enis GÜNERİ
Pages
8–13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Better results may be expected particularly in young and non-diabetic patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate hyperbaric oxygen HBO therapy as a salvage treatment option for sudden sensorineural hearing loss SSNHL and analyze factors influencing treatment outcomes.
📊
Key Findings & Data:Patients and Methods: Charts of 27 patients 20 males, 7 females; mean age 50.8 years; range, 30 to 74 years who received HBO therapy as salvage treatment were retrospectively evaluated between January 2007 and December 2017.
💡
Conclusion & Impact:Better results may be expected particularly in young and non-diabetic patients.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Hearing loss · hyperbaric oxygen · sensorineural

Abstract

Objectives: This study aims to evaluate hyperbaric oxygen HBO therapy as a salvage treatment option for sudden sensorineural hearing loss SSNHL and analyze factors influencing treatment outcomes. Patients and Methods: Charts of 27 patients 20 males, 7 females; mean age 50.8 years; range, 30 to 74 years who received HBO therapy as salvage treatment were retrospectively evaluated between January 2007 and December 2017. Patients’ demographics, time between onset of SSNHL to the initiation of steroid and HBO treatments, audiogram curves, tinnitus, vestibular symptoms, and pure tone audiometry results before and after steroid and HBO therapies were evaluated. Siegle’s criteria were used to evaluate treatment outcomes. Results: According to Siegle’s criteria, while seven patients had slight improvement, partial improvement was seen in two patients. With HBO therapy, a statistically significant improvement was seen at 250, 500, and 8000 Hz frequencies. Diabetes mellitus and patients’ age were related with treatment outcomes. Conclusion: Hyperbaric oxygen therapy may be beneficial as a salvage treatment option in some patients. Better results may be expected particularly in young and non-diabetic patients.

🔖

Cite This Article

OLLGUN, Y., EMRE, F. Y., ÇAKIR, A., KIRKIM, G., ELLİDOKUZ, H., GÜNERİ, E. (2020). Hyperbaric oxygen therapy: The last remedy for sudden sensorineural hearing loss?. The Turkish Journal of Ear Nose and Throat, Cilt: 30 - Sayı: 1, 8–13. https://ajindex.com/articles/362528

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146:S1-35. Edizer DT, Çelebi Ö, Hamit B, Baki A, Yiğit Ö. Recovery of Idiopathic Sudden Sensorineural Hearing Loss. J Int Adv Otol 2015;11:122-6.
  2. Ajduk J, Ries M, Trotic R, Marinac I, Vlatka K, Bedekovic V. Hyperbaric oxygen therapy as salvage therapy for sudden sensorineural hearing loss. J Int Adv Otol 2017;13:61-4.
  3. Yang CH, Wu RW, Hwang CF. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Otol Neurotol 2013;34:1411-6. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467-73.
  4. Muzzi E, Zennaro B, Visentin R, Soldano F, Sacilotto C. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol 2010;124:e2. Aslan I, Oysu C, Veyseller B, Baserer N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 2002;126:121-6.
  5. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 2007;133:582-6.
  6. Sun H, Qiu X, Hu J, Ma Z. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high- frequency sudden sensorineural hearing loss. Am J Otolaryngol 2018;39:531-5.
  7. Tsounis M, Psillas G, Tsalighopoulos M, Vital V, Maroudias N, Markou K. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial. Eur Arch Otorhinolaryngol 2018;275:103-10.
  8. Ocak E, Beton S, Kesici GG, Aktürk T. Can Intratympanic Steroid Be Initial Therapy for Sudden Sensorineural Hearing Loss? Turk Arch Otolaryngol 2014;52:12-6.
  9. Suzuki H, Wakasugi T, Kitamura T, Koizumi H, Do BH, Ohbuchi T. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss. Ann Otol Rhinol Laryngol 2018;127:235-40.
  10. Horn CE, Himel HN, Selesnick SH. Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otol Neurotol 2005;26:882-9.
  11. Pezzoli M, Magnano M, Maffi L, Pezzoli L, Marcato P, Orione M, Cupi D, Bong